维普中文期刊产品整合服务
10篇 您的检索式:作者名="John D Clements"
    题名 作者 年代 出处 被引量
1Quality Improvement Guidelines for the Treatment of Lower Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal显示文摘Suresh Vedantham Patricia E. Thorpe John F. Cardella Clement J. Grassi Nilesh H. Patel Hector Ferral Lawrence V. Hofmann Bertrand M. Janne d’Othée Vittorio P. Antonaci Elias N. Brountzos Daniel B. Brown Louis G. Martin Alan H. Matsumoto Steven G. Meranze 2006Journal of Vascular and Interventional Radiology2006,,3:3
2Reporting Standards for Endovascular Treatment of Lower Extremity Deep Vein Thrombosis显示文摘Suresh Vedantham Clement J. Grassi Hector Ferral Nilesh H. Patel Patricia E. Thorpe Vittorio P. Antonacci Bertrand M. Janne d’Othée Lawrence V. Hofmann John F. Cardella Sanjoy Kundu Curtis A. Lewis Marc S. Schwartzberg Robert J. Min David Sacks 2009Journal of Vascular and Interventional Radiology2009,,7:1
3Quality Improvement Guidelines for the Treatment of Lower Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal显示文摘Suresh Vedantham Patricia E. Thorpe John F. Cardella Clement J. Grassi Nilesh H. Patel Hector Ferral Lawrence V. Hofmann Bertrand M. Janne d’Othée Vittorio P. Antonaci Elias N. Brountzos Daniel B. Brown Louis G. Martin Alan H. Matsumoto Steven G. Meranze 2009Journal of Vascular and Interventional Radiology2009,,7:1
4Rotavirus 2/6 viruslike particles administered intranansally with cholera toxin,Escherichia coli heat-labile toxin (LT),and LT-R192G induce protection from Rotavirus challenge显示文摘Christine M Oneal John D Clements 1998Virolo1998,72,:1
5Primary closure,routine patching,and eversion endarterectomy what is the current state of the literature supporting use of these techniques显示文摘John B Paul F Clement D 2007Semin Vasc Surg2007,20,:1
6Quality Improvement Guidelines for the Treatment of Lower Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal显示文摘Suresh Vedantham Patricia E. Thorpe John F. Cardella Clement J. Grassi Nilesh H. Patel Hector Ferral Lawrence V. Hofmann Bertrand M. Janne d'Othée Vittorio P. Antonaci Elias N. Brountzos Daniel B. Brown Louis G. Martin Alan H. Matsumoto Steven G. Meranze 2006Journal of Vascular and Interventional Radiology2006,,3:1
7Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease显示文摘Wang D John SA Clements JL 2005Int Immunol2005,17,:1
8Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and au- toimmune disease 显示文摘Wang D John SA Clements JL 2005Int Immunol2005,17,9:1
9Ets-1 deficiency leads to altered B cell differentiation,hyperresponsiveness to TLR9 and autoimmune disease显示文摘Wang D John SA Clements JL 2005Int Immunol2005,17,:1
10Developing a coordinate-based strategy to support cognitive targeted prostate biopsies and correlative spatial-histopathological outcome analysis显示文摘Lack of investment for magnetic resonance(MR)fusion systems is an obstacle to deliver targeted prostate biopsies within the prostate cancer diagnostic pathway.We developed a coordinate-based method to support cognitive targeted prostate biopsies and then performed an audit on cancer detection and the location of lesions.In each patient,the prostate is considered as two separate hemiprostates,and each hemiprostate is divided into 4×4×4 units.Each unit is therefore defined by a three-dimensional coordinate.We prospectively applied our coordinates approach to target 106 prostatic lesions in 93 men.Among 45(of 106;42.5%)lesions positive for cancer,27 lesions(60.0%)harbored clinically significant disease.PSA density was significantly higher in patients with proven cancer(median:0.264 ng ml^(-2))when compared to the noncancer group(median:0.145 ng ml-2;P=0.003,Wilcoxon ranksum test).Lesions with Prostate Imaging-Reporting and Data System(PIRADS)score of 5 were found to have a cancer incidence of 65.2%,while PI RADS 4 and 3 lesions have a lower risk of cancer detection,as expected,at 37.3%and 31.3%,respectively.The probability of a lesion being cancerous in our series significantly decreases as we go from the“apex-to-base”dimension(odds ratio[OR]:2.62,95%confidence interval[Cl]:1.55-4.44,P=0.00034).Our analysis also indicates that the probability of cancer decreases as the prostate volume increases(OR:1.03,95%Cl:1.01-1.05,P=0.00327).Based on this feasibility study,the use of coordinates to guide cognitive targeted prostate biopsies warrants future validation study in additional centers.Keiran D Clement Lizzy Day Helen Rooney Matt Neilson Fiona Birrell Mark Salji Elizabeth Norm an Ross Clark Amit Patel John Morrison Hing Y Leung 2021Asian Journal of Andrology2021,23,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费